Cofoe Medical Technology Co Ltd
SZSE:301087

Watchlist Manager
Cofoe Medical Technology Co Ltd Logo
Cofoe Medical Technology Co Ltd
SZSE:301087
Watchlist
Price: 53.02 CNY -0.62% Market Closed
Market Cap: ¥11.1B

EV/GP

5.3
Current
22%
More Expensive
vs 3-y average of 4.3

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
5.3
=
Enterprise Value
¥10B
/
Gross Profit
¥1.8B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
5.3
=
Enterprise Value
¥10B
/
Gross Profit
¥1.8B

Valuation Scenarios

Cofoe Medical Technology Co Ltd is trading above its 3-year average

If EV/GP returns to its 3-Year Average (4.3), the stock would be worth ¥43.36 (18% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-18%
Maximum Upside
+157%
Average Upside
46%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 5.3 ¥53.02
0%
3-Year Average 4.3 ¥43.36
-18%
5-Year Average 4.6 ¥46.36
-13%
Industry Average 8.4 ¥84.14
+59%
Country Average 13.6 ¥136.04
+157%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
CN
Cofoe Medical Technology Co Ltd
SZSE:301087
11.1B CNY 5.3 29.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.6B USD 23.6 56.9
US
Abbott Laboratories
NYSE:ABT
155.4B USD 6.1 24.8
US
Stryker Corp
NYSE:SYK
112.7B USD 7.6 34.7
IE
Medtronic PLC
NYSE:MDT
102.7B USD 5.3 22.3
US
Boston Scientific Corp
NYSE:BSX
83.8B USD 6.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 9.2 44.5
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 5.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.2B USD 17.1 42.7
US
Becton Dickinson and Co
NYSE:BDX
42.5B USD 5.8 24.2
US
Resmed Inc
NYSE:RMD
29.9B USD 8.8 20.1

Market Distribution

Lower than 81% of companies in China
Percentile
19th
Based on 6 967 companies
19th percentile
5.3
Low
0 — 8
Typical Range
8 — 23.3
High
23.3 —
Distribution Statistics
China
Min 0
30th Percentile 8
Median 13.6
70th Percentile 23.3
Max 17 898 541.1

Cofoe Medical Technology Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Health Care

In the vibrant landscape of China's medical device industry, Cofoe Medical Technology Co Ltd emerges as a dynamic player, adeptly navigating the intersection of innovation and practicality. Founded with a mission to enhance healthcare accessibility, the company specializes in the design, production, and distribution of a broad spectrum of medical devices. From blood pressure monitors to thermometers, Cofoe's portfolio is tailored to meet the everyday health monitoring needs of consumers, hospitals, and clinics alike. The firm leverages its extensive research and development capabilities to stay ahead in a rapidly evolving market, ensuring its product offerings are both cutting-edge and user-friendly. Cofoe's business model is intricately woven around capturing value through both scale and precision. The company capitalizes on China's extensive manufacturing capabilities to produce cost-effective yet high-quality medical devices. It maintains a robust supply chain network that ensures efficiency and timely delivery. Moreover, Cofoe channels its marketing efforts through a mix of traditional retail outlets and burgeoning e-commerce platforms, effectively expanding its footprint both domestically and in selected international markets. By focusing on quality control, regulatory compliance, and customer satisfaction, Cofoe reinforces its brand reputation, thereby creating a sustainable competitive advantage and driving revenue growth.

Intrinsic Value
41.43 CNY
Overvaluation 22%
Intrinsic Value
Price ¥53.02
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett